IRIX vs TROW · rev $12.6M vs P/E 12, rev $3.76B
IRIDEX Corporation (IRIX) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
IRIDEX Corporation (IRIX) is a medical devices company listed on US.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported IRIX revenue for 2026-07-04 was $12.6M. Net income was -$1.3M. Revenue was up 6.5% from 2026-04-04 to 2026-07-04. IRIX currently screens at market cap $19.0M.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
IRIX currently screens at market cap $19.0M. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the IRIX and TROW stock pages for the full models.
Not investment advice.